GLP-1, or Glucagon-like peptide-1, medications, similar to Ozemppic and Wegovy, are becoming more accessible, and while the ...
Emerging research suggests that certain diabetes medications could offer benefits beyond blood sugar control, potentially ...
The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals) ...
Experts say patients should adjust dosage, try prescribed and over-the-counter drugs to help with symptom management and ...
Elon Musk has dished the secrets behind his recent weight loss transformation.
The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...
The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...
The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...
Structure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) rose 5.6% on Thursday . The company traded as high as $29.87 and last traded at $29.84. Approximately 85,014 shares changed hands during mid ...
FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...
Anti-obesity medication use was associated with reduced alcohol consumption among patients in a telehealth medical weight ...
The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback